Table 4

Differences between subjects reporting GIT problems and those who did not report GIT symptoms following supplementation
Pre-supplementation Post-supplementation
Measure Subjects reporting GIT symptoms post-supplement (mean) Subjects GIT symptom free post-supplement (mean) P value Subjects reporting GIT symptoms post- supplement (mean) Subjects GIT symptom free post-supplement (mean) P value
General health indices
 Neurological index 1.3 0.5 < 0.004 1.0 0.4 ns
Chalder fatigue scale
 Total fatigue scores 14.2 11.8 ns 12.6 8.9 ns
Amino acids
 (Relative % abundance)
 Asparagine 6.60% 4.78% < 0.03 6.11% 4.89% ns
 Hydroxylysine 1.62% 1.15% < 0.05 1.72% 1.32% ns
 Hydroxyproline 0.58% 0.34% < 0.04 0.65% 0.52% ns

Statistical test: Mann–Whitney U. n = 5 and 12 for the participants reporting GIT symptoms and those who did not report GIT symptoms respectively. ns = statistically non-significant.

Dunstan et al.

Dunstan et al. Nutrition Journal 2013 12:115   doi:10.1186/1475-2891-12-115

Open Data